Transgene 和 Bio Invent 将在2025年ESMO上提交有关癌症抗争病毒BT-001的最新数据。 Transgene and BioInvent to present latest data on cancer-fighting virus BT-001 at ESMO 2025.

Transgene和BioInvent将在2025年10月17日至21日在柏林举行的EMSO年会上提交关于其抗癌病毒BT-001的最新数据。 Transgene and BioInvent will present updated data on their cancer-fighting virus BT-001 at the ESMO Annual Meeting in Berlin, October 17-21, 2025. 正在对BT-001进行单独测试,并与MSD的KEYTRUDA进行1/2a阶段的安全性和治疗先进固态肿瘤有效性研究。 BT-001 is being tested both alone and with MSD's KEYTRUDA in a Phase 1/2a study for safety and effectiveness in treating advanced solid tumors. 介绍将包括目前这项研究的最新临床结果。 The presentation will include the latest clinical results from this ongoing research.